Patents by Inventor Hiromi Kazuno

Hiromi Kazuno has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cytidine derivative-containing antitumor agent for continuous intravenous administration
    Patent number: 8642572
    Abstract: A method for administering ECyd to a patient that realizes a continuous therapy without expressing peripheral neurotoxicity caused by ECyd and that exhibits an excellent therapeutic effect and prolongs patient survival. An antitumor agent containing ECyd or a salt thereof and a method of administering it to a cancer patient through continuous intravenous administration at a dose of 1.30 to 8.56 mg/m2 in terms of ECyd, for each administration period of 2 to 336 hours.
    Type: Grant
    Filed: April 4, 2008
    Date of Patent: February 4, 2014
    Assignee: Taiho Pharmaceutical Co., Ltd.
    Inventors: Hiromi Kazuno, Katsuhisa Koizumi, Akira Mita
  • Anti-tumor agent comprising cytidine derivative and carboplatin
    Patent number: 8586561
    Abstract: Provision of a novel combined therapy with ECyd, which therapy exhibits remarkable antitumor effect and gives less adverse effects. The invention provides an antitumor agent containing, in combination, 1-(3-C-ethynyl-?-D-ribopentofuranosyl)cytosine or a salt thereof and carboplatin.
    Type: Grant
    Filed: March 26, 2009
    Date of Patent: November 19, 2013
    Assignees: Taiho Pharmaceutical Co., Ltd.
    Inventor: Hiromi Kazuno
  • Anti-tumor agent comprising cytidine derivative and carboplatin
    Patent number: 8557791
    Abstract: Provision of a novel combined therapy with ECyd, which therapy exhibits remarkable antitumor effect and gives less adverse effects. The invention provides an antitumor agent containing, in combination, 1-(3-C-ethynyl-?-D-ribopentofuranosyl) cytosine or a salt thereof and carboplatin.
    Type: Grant
    Filed: March 26, 2009
    Date of Patent: October 15, 2013
    Assignees: Taiho Pharmaceutical Co., Ltd.
    Inventor: Hiromi Kazuno
  • ANTI-TUMOR AGENT COMPRISING CYTIDINE DERIVATIVE AND CARBOPLATIN
    Publication number: 20110118205
    Abstract: Provision of a novel combined therapy with ECyd, which therapy exhibits remarkable antitumor effect and gives less adverse effects. The invention provides an antitumor agent containing, in combination, 1-(3-C-ethynyl-?-D-ribopentofuranosyl)cytosine or a salt thereof and carboplatin.
    Type: Application
    Filed: March 26, 2009
    Publication date: May 19, 2011
    Applicants: Taiho Pharmaceutical Co., Ltd., Takuma Sasaki, Akira Matsuda
    Inventor: Hiromi Kazuno
  • CYTIDINE DERIVATIVE-CONTAINING ANTITUMOR AGENT FOR CONTINUOUS INTRAVENOUS ADMINISTRATION
    Publication number: 20100120709
    Abstract: To provide a method for administering ECyd to a patient, which realizes a continuous therapy without expressing peripheral neurotoxicity caused by ECyd and which exhibits an excellent therapeutic effect with ensuring prolongation of the survival of the patient. The invention provides an antitumor agent containing ECyd or a salt thereof, which is administered to a cancer patient through continuous intravenous administration at a dose of 1.30 to 8.56 mg/m2 as reduced to ECyd, for each administration period of 2 to 336 hours.
    Type: Application
    Filed: April 4, 2008
    Publication date: May 13, 2010
    Applicant: TAIHO PHARMACEUTICAL CO., LTD.
    Inventors: Hiromi Kazuno, Katsuhisa Koizumi, Akira Mita